New policy brief: 76% of FDA-authorized medical AI devices are radiology tools — yet most lack robust post-deployment monitoring. Our latest brief introduces a practical framework for real-time performance oversight of clinical AI. https://
hai.stanford.edu/policy/operati
onalizing-real-time-monitoring-of-clinical-ai
…
Policy Brief: Monitoring AI in FDA-Authorized Medical Devices
By
–
